Free Trial

Kezar Life Sciences (KZR) Earnings Date, Estimates & Call Transcripts

Kezar Life Sciences logo
$4.11 -0.21 (-4.86%)
Closing price 04/15/2025 04:00 PM Eastern
Extended Trading
$4.18 +0.07 (+1.82%)
As of 04/15/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Kezar Life Sciences Earnings Summary

Upcoming
Earnings Date
May. 8Before Market OpensEstimated
Consensus EPS
(Mar. 25)
-$2.71
Actual EPS
(Mar. 25)
-$2.77 Missed By -$0.06

Kezar Life Sciences announced Q4 2024 & Study Result earnings on March 25, 2025, reporting an EPS of -$2.77, which missed the consensus estimate of -$2.71 by $0.06. With a trailing EPS of -$11.55, Kezar Life Sciences' earnings are expected to decrease next year, from ($4.39) to ($8.31) per share.

Q4 2024 & Study Result Earnings Resources

KZR Upcoming Earnings

Kezar Life Sciences' Q1 2025 earnings is scheduled for Thursday, May 8, 2025, with a conference call scheduled at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get Kezar Life Sciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Kezar Life Sciences and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

KZR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Remove Ads

Kezar Life Sciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20252-$2.73-$2.56-$2.65
Q2 20252-$2.75-$2.57-$2.66
Q3 20252-$2.78-$2.59-$2.69
Q4 20252-$2.80-$2.61-$2.71
FY 20258-$11.06-$10.33-$10.70
Q1 20261-$2.95-$2.95-$2.95
Q2 20261-$3.03-$3.03-$3.03
Q3 20261-$3.10-$3.10-$3.10
Q4 20261-$3.16-$3.16-$3.16
FY 20264($12.24)($12.24)($12.24)
Remove Ads

Kezar Life Sciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/8/2025
(Estimated)
-------
3/25/2025Q4 2024 & Study Result-$2.71-$2.77 -$0.06-$2.77--
11/12/2024--$3.03-$2.78+$0.25-$2.78$4.00M-
8/13/2024Q2 2024-$3.20-$2.80+$0.40-$0.26--
5/9/2024Q1 2024-$3.40-$3.00+$0.40-$0.30--
3/14/2024Q4 2023-$3.90-$3.50+$0.40-$0.26--
11/13/2023Q3 2023-$3.60-$3.20+$0.40-$0.32$0.50M$7.00M
8/10/2023Q2 2023-$3.30-$3.40 -$0.10-$0.34--
5/11/2023Q1 2023-$2.80-$3.10 -$0.30-$0.31--

Kezar Life Sciences Earnings - Frequently Asked Questions

Kezar Life Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based off last year's report dates. Learn more on KZR's earnings history.

In the previous quarter, Kezar Life Sciences (NASDAQ:KZR) missed the analysts' consensus estimate of ($2.71) by $0.06 with a reported earnings per share (EPS) of ($2.77). Learn more on analysts' earnings estimate vs. KZR's actual earnings.

The conference call for Kezar Life Sciences's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Kezar Life Sciences's latest earnings report can be read online.
Read Transcript

Kezar Life Sciences's earnings report can be found in their filing with the SEC.
View SEC filing

Kezar Life Sciences (NASDAQ:KZR) has a recorded annual revenue of $7 million.

Kezar Life Sciences (NASDAQ:KZR) has a recorded net income of -$101.87 million. KZR has generated -$11.55 earnings per share over the last four quarters.

Kezar Life Sciences's earnings are expected to decrease from ($4.39) per share to ($8.31) per share in the next year.

More Earnings Resources from MarketBeat

Remove Ads


This page (NASDAQ:KZR) was last updated on 4/16/2025 by MarketBeat.com Staff
From Our Partners